SphereBio develops biotech platforms that deliver molecules to cells, training them to generate specific responses to health issues. The company is now using platforms to offer pharmaceutical and veterinary companies a novel approach to potentiate vaccines and therapeutics tailored to specific diseases, such as cancer. It was founded in 2023.
Something missing or incorrect on this page? Help us enrich this information
